alexa Pharmacological Options in Cushing's Syndrome
ISSN: 2161-1017

Endocrinology & Metabolic Syndrome
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Pharmacological Options in Cushing's Syndrome

Durán-Pérez Edgar Gerardo1*, Moreno-Loza Oscar Tarcicio2, Segovia-Palomo Antonio2, Chavira-López Ismael Javier2, Carrasco-Tobón German2 and Lujano Nicolás Leslye Asela3

1Division of Endocrinology, Hospital Regional High Specialty Bajio, Leon Guanajuato, Mexico

2Deparment Endocrinology, General Hospital of Mexico, Mexico Mexico City, Mexico

3Division of Gastroenterology, Hospital Regional High Specialty Bajio, Leon Guanajuato, Mexico

corresponding Author:
Edgar Perez Duran Geardo
Highly Specialized Regional Hospital Bajio
Leon Guanajuato, Mexico
Tel: 52-477-2672000 ext 1414
Fax: 52-477-2672000
E-mail: [email protected]

Received Date: November 28, 2012; Accepted Date: December 28, 2012; Published Date: January 03, 2013

Citation: Edgar Gerardo DP, Oscar Tarcicio ML, Antonio SP, Ismael Javier CL, German CT, et al. (2013) Pharmacological Options in Cushing’s Syndrome. Endocrinol Metab Synd 2:110. doi: 10.4172/2161-1017.1000110

Copyright: © 2013 Edgar Gerardo DP, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



The endogenous Cushing’s syndrome is a pathology which represents a diagnostic and therapeutic challenge for the specialist. Even though surgery is the first-line treatment, it is common to resort to pharmacological therapy in the preoperative setting because of the clinical instability or because the purpose is improving the medical condition of the patient before the surgery. Furthermore, because of the low successful rates with the surgical approach, the adjuvant pharmacological treatment ranks the first place because its purpose is to improve the possibilities of disease remission. This review deals with the current pharmacological therapies for the management of endogenous Cushing’s syndrome.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version